2020 American Transplant Congress
Acute Kidney Injury in Deceased Organ Donors and Kidney Transplant Outcomes Using a Novel Data Source
Perelman School of Medicine, University of Pennsyl, Philadelphia, PA
*Purpose: The kidney shortage necessitates innovative approaches to expand the donor pool. Acute kidney injury(AKI) is common among deceased donors and a risk factor for…2020 American Transplant Congress
Recurrent Diabetic Nephropathy Post Kidney Transplant is Associated with High Risk of Mortality
*Purpose: The goal of the study was to determine the incidence of recurrent diabetic kidney disease (DKD) after kidney transplantation (KT) and assess its correlation…2020 American Transplant Congress
Living Donor Liver Transplantation Demonstrated Superiority to Deceased Donor Transplantation after Adult-To-Adult Liver Transplantation in Cumulative Single-Center Retrospective Cohort Study of 19 Years
*Purpose: Living donor liver transplantation (LDLT) is an alternative way to deceased donor liver transplantation (DDLT). LDLT and DDLT showed similar short-term outcomes of recipient…2020 American Transplant Congress
Posttransplant Program Evaluations: Long-Term Outcomes are More Relevant to Patients Than Short-Term Outcomes
*Purpose: Posttransplant evaluations with 1-year follow-up are criticized for not identifying clinically meaningful differences between programs, not being the right outcome for patients, or including…2020 American Transplant Congress
Impact of Functional Status on Outcomes of Simultaneous Pancreas-Kidney Transplantation: Risks and Opportunities for Patient Benefit
*Purpose: The impact of functional status on survival among simultaneous pancreas-kidney transplant (SPKT) candidates and recipients is not well described.*Methods: We examined national Scientific Registry…2020 American Transplant Congress
A Data-Driven Approach to Defining the Volume-Outcome Relationship in Liver Transplantation
Baylor College of Medicine, Houston, TX
*Purpose: Patients with end-stage liver disease (ESLD) who undergo liver transplantation experience significant survival benefit, with a 1-year survival rate after liver transplantation of 91%.…2020 American Transplant Congress
The Efficacy of Spheroidal Hepatocyte in Hepatocyte Transplantation
Department of Gastroenterological Surgery Ⅰ Hokkaido University Graduate School, Sapporo, Japan
*Purpose: Hepatocyte transplantation (HCTx) has been expected as a next generation cell therapy alternative to liver transplantation. Following HCTx, the liver function improves in many…2020 American Transplant Congress
Causes of Kidney Allograft Loss (GL) in the Current Era of Donor-Specific Alloantibody (DSA) Testing
1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Scottsdale, AZ
*Purpose: The goal of this study was to examine the causes and risk factors (RF) for renal GL in the era since the widespread adoption…2020 American Transplant Congress
A Proof-of-Principle Study to Evaluate Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance (ASCOTT)
*Purpose: Long-term survival of recipients of solid organ transplants is limited by chronic rejection, disease recurrence and immunosuppression-induced toxicity. Self-tolerance is established after autologous hematopoietic…2020 American Transplant Congress
History of Coronary Artery Disease Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort
*Purpose: Coronary artery disease (CAD) is common in patients of advanced age and does not preclude liver transplantation (LT) if adequately treated. We aimed to…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 223
- Next Page »